ArticleScientific reports2015

The multikinase inhibitor Sorafenib enhances glycolysis and synergizes with glycolysis blockade for cancer cell killing.

Valentina Tesori et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.